Nifuroxazide ameliorates pulmonary fibrosis by blocking myofibroblast genesis: a drug repurposing study

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a serious interstitial lung disease with a complex pathogenesis and high mortality. The development of new drugs is time-consuming and laborious; therefore, research on the new use of old drugs can save time and clinical costs and even avoid serious...

Descripción completa

Detalles Bibliográficos
Autores principales: Gan, Cailing, Zhang, Qianyu, Liu, Hongyao, Wang, Guan, Wang, Liqun, Li, Yali, Tan, Zui, Yin, Wenya, Yao, Yuqin, Xie, Yongmei, Ouyang, Liang, Yu, Luoting, Ye, Tinghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848910/
https://www.ncbi.nlm.nih.gov/pubmed/35172837
http://dx.doi.org/10.1186/s12931-022-01946-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848910/
https://www.ncbi.nlm.nih.gov/pubmed/35172837
http://dx.doi.org/10.1186/s12931-022-01946-6

Ejemplares similares